Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation TCT 2016

NIRS Detection of Vulnerable Plaque: The Story Is Intensifying

Presenter: John A. Ambrose, Peter H. Stone, David Erlinge

November 01, 2016

Presentation TCT 2016

Hypothermia and Cardiac Arrest: New Data on Patient Selection, Timing and Cooling Protocols

Presenter: Cindy L. Grines, Holger Thiele, David Erlinge

October 31, 2016

Presentation TCT 2016

TCT 143: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Patients with History of Malignancy

Presenter: Laurent Bonello, David Erlinge

October 30, 2016

Presentation TCT 2016

TCT 142: Temporal Trends in Incidence of Acute Myocardial Infarction in Patients with Malignancy Undergoing Percutaneous Coronary Intervention (PCI)

Presenter: Laurent Bonello, David Erlinge

October 30, 2016

Presentation TCT 2016

TCT 141: Percutaneous Coronary Intervention (PCI) for Acute Myocardial Infarction in Patients with Systemic lupus Erythematosus: Analysis from Nationwide Inpatient Sample (NIS)

Presenter: Laurent Bonello, David Erlinge

October 30, 2016

Presentation TCT 2016

TCT 100: Asians Suffer the Highest In-Hospital Mortality Rates After Acute Coronary Syndrome Despite High Use of Early Invasive Procedures

Presenter: Laurent Bonello, David Erlinge

October 30, 2016

Presentation TCT 2015

Case 4: NIRS in Acute Coronary Syndrome Recognition and Treatment of Neoatherosclerosis

Presenter: Ryan D. Madder, Gary S. Mintz, David Erlinge

October 13, 2015

Presentation TCT 2015

Procedural Anticoagulants in Sweden: Results From the SCAAR Registry and Rationale for VALIDATE-SWEDEHEART

Presenter: John A. Bittl, Robert A. Harrington, David Erlinge

October 12, 2015

Presentation TCT 2015

Prospective Identification of NonFlow Limiting Vulnerable Plaques and Vulnerable Patients: Data From Grayscale and RF-IVUS, OCT, and NIRS for Predicting Future Events

Presenter: Fernando Alfonso, Akiko Maehara, David Erlinge

October 11, 2015

Presentation TCT 2015

Nonculprit Lesions in STEMI Patients With Multivessel Disease: Is the Issue Ischemia or Vulnerable Plaque?

Presenter: Thomas Engstroem, Barry D. Rutherford, David Erlinge

October 11, 2015

Presentation TCT 2014

Hypothermia #2: Critical Appraisal of Hypothermia Outcomes for Infarct Size Reduction: Integrated Analysis of All Clinical Studies

Presenter: Francisco Fdez-Aviles, Abhiram Prasad, David Erlinge

September 16, 2014

Presentation TCT 2014

NIRS Utility in the Unstable Patient With ACS/NSTEMI

Presenter: Gary S. Mintz, Patrick W. Serruys, Ryan D. Madder, David Erlinge

September 13, 2014

Presentation TCT 2013

Hypothermia To Reduce Infarct Size 1: From Predicate Studies to CHILL-MI

Presenter: David Erlinge

October 31, 2013

Presentation TCT 2013

RF-IVUS, OCT, and NIRS Findings in Patients Presenting With STEMI

Presenter: David Erlinge

October 31, 2013

Presentation TCT 2013

Case 2: Acute Myocardial Infarction with Multiple Culprits

Presenter: David Erlinge

October 31, 2013

Presentation TCT 2013

Vulnerable Plaque Diagnosis by NIRS-IVUS (with Case Vignettes): Current Data and PROSPECT II

Presenter: David Erlinge

October 30, 2013

Presentation TCT 2013

CHILL-MI: A Prospective, Randomized Trial of Therapeutic Hypothermia in Patients with Acute Myocardial Infarction Undergoing Primary PCI

Presenter: David Erlinge

October 30, 2013

News Conference News TCT 2013

CHILL-MI: Therapeutic Hypothermia Most Effective in Early Anterior STEMI

October 30, 2013

Presentation TCT 2013

Unraveling the ACS Culprit: Insights from NIRS-IVUS

Presenter: David Erlinge

October 28, 2013

Presentation TCT 2013

Point-of-Care Genetic Testing of Eleven CYP2C19 Single Nucleotide Polymorphisms Identifies Extensive and Reduced Metabolizers of Clopidogrel With High Accuracy in Patients With...

Presenter: David Erlinge, Stefan James, Suman Duvvuru, Joseph Jakubowski, Henrik Wanger, Christoph Varenhorst, Udaya Tantry, Patricia Brown, David Small, Brian Moser, Scott Sundseth, Joseph Walker, Kenneth Winters, Paul Gurbel

January 31, 2013

Advertisement

NIRS Detection of Vulnerable Plaque: The Story Is Intensifying

Hypothermia and Cardiac Arrest: New Data on Patient Selection, Timing and Cooling Protocols

TCT 143: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Patients with History of Malignancy

TCT 142: Temporal Trends in Incidence of Acute Myocardial Infarction in Patients with Malignancy Undergoing Percutaneous Coronary Intervention (PCI)

TCT 141: Percutaneous Coronary Intervention (PCI) for Acute Myocardial Infarction in Patients with Systemic lupus Erythematosus: Analysis from Nationwide Inpatient Sample (NIS)

TCT 100: Asians Suffer the Highest In-Hospital Mortality Rates After Acute Coronary Syndrome Despite High Use of Early Invasive Procedures

Case 4: NIRS in Acute Coronary Syndrome Recognition and Treatment of Neoatherosclerosis

Procedural Anticoagulants in Sweden: Results From the SCAAR Registry and Rationale for VALIDATE-SWEDEHEART

Prospective Identification of NonFlow Limiting Vulnerable Plaques and Vulnerable Patients: Data From Grayscale and RF-IVUS, OCT, and NIRS for Predicting Future Events

Nonculprit Lesions in STEMI Patients With Multivessel Disease: Is the Issue Ischemia or Vulnerable Plaque?

Hypothermia #2: Critical Appraisal of Hypothermia Outcomes for Infarct Size Reduction: Integrated Analysis of All Clinical Studies

NIRS Utility in the Unstable Patient With ACS/NSTEMI

Hypothermia To Reduce Infarct Size 1: From Predicate Studies to CHILL-MI

RF-IVUS, OCT, and NIRS Findings in Patients Presenting With STEMI

Case 2: Acute Myocardial Infarction with Multiple Culprits

Vulnerable Plaque Diagnosis by NIRS-IVUS (with Case Vignettes): Current Data and PROSPECT II

CHILL-MI: A Prospective, Randomized Trial of Therapeutic Hypothermia in Patients with Acute Myocardial Infarction Undergoing Primary PCI

CHILL-MI: Therapeutic Hypothermia Most Effective in Early Anterior STEMI

Unraveling the ACS Culprit: Insights from NIRS-IVUS

Point-of-Care Genetic Testing of Eleven CYP2C19 Single Nucleotide Polymorphisms Identifies Extensive and Reduced Metabolizers of Clopidogrel With High Accuracy in Patients With...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content